Volanesorsen
ISIS 304801-CS13
Phase 1 small_molecule completed
Quick answer
Volanesorsen for Abnormalities, Cardiovascular is a Phase 1 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Abnormalities, Cardiovascular
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed